A medical device company focused on transforming vascular closure for the benefit of patients, hospitals and physicians. Our products address the over 5.6 million catheter-based coronary, peripheral and electrophysiology procedures in the United States that require vascular access site closure each year. We have purposefully built and optimized our VASCADE family of products to address the key clinical and economic challenges of manual compression, the traditional standard of care for vascular closure in these procedures.
Lead Underwriter
BofA Securities, Inc, J.P. Morgan Securities LLC
Co-Managers
Canaccord Genuity LLC, Stifel Nicolaus & Company, Incorporated
